Loxapine
From Wikipedia, the free encyclopedia
| |
| Loxapine
| |
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | 1977-10-2 |
| ATC code | N05AH01 |
| PubChem | 3964 |
| DrugBank | APRD00574 |
| Chemical data | |
| Formula | C18H18ClN3O |
| Mol. weight | 327.808 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | Oral-4 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Loxapine (sold as Loxapac®, Loxitane®) is a typical antipsychotic medication, used primarily in the treatment of schizophrenia. It is a member of the dibenzodiazepine family and structurally related to clozapine. Several researchers have argued that Loxapine may behave as an atypical antipsychotic PMID 10340686
[edit] Side effects
Side effects include tardive dyskinesia, neuroleptic malignant syndrome, extrapyramidal side effects, tremor and sedation.


